Pharmaceutical actuation in intensive care units: contributions to rational use of drugs

Objective: Evaluate the performance of the clinical pharmacist in Adult Intensive Care Units of a special-sized hospital, wherein pharmacotherapeutic follow-up is the main activity developed by the pharmacist residing in intensive care. Methods: This is an observational, cross-sectional study with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eduarda C. Maciel, Renan P. Borges, Áquila S. Portela
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d0dc9877dd8d4e70984ff95ed9dc592a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d0dc9877dd8d4e70984ff95ed9dc592a
record_format	dspace
spelling	oai:doaj.org-article:d0dc9877dd8d4e70984ff95ed9dc592a2021-11-28T02:45:26ZPharmaceutical actuation in intensive care units: contributions to rational use of drugs10.30968/rbfhss.2019.104.04292179-59242316-7750https://doaj.org/article/d0dc9877dd8d4e70984ff95ed9dc592a2020-04-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/429https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: Evaluate the performance of the clinical pharmacist in Adult Intensive Care Units of a special-sized hospital, wherein pharmacotherapeutic follow-up is the main activity developed by the pharmacist residing in intensive care. Methods: This is an observational, cross-sectional study with a quantitative approach, carried out in Adult Intensive Care Units, from March to June 2018. Data were collected from the Clinical Pharmacy Service, by means of already established indicators. Results: During the study period, 958 patients were admitted and 664 were included in the study. Regarding the place of hospitalization, 57% of the patients included in the study were hospitalized in the Post-operative Intensive Care Unit and 43% in the Clinical Intensive Care Unit. The suggested interventions were well accepted (99.6%), and in the clinical intensive care unit, the number of interventions performed and the cost saving were higher in all months of the study. The main interventions were drugs inclusion / withdrawal, dose reduction, infusion time and dilution. Of the interventions accepted, 25% generated cost savings, saving R $ 163,656.40 in total, and the types of interventions related to the most frequent cost saving were withdrawal of the drug (58.5%), dose reduction (32.6%) and change of pharmaceutical formula (3.0%). Conclusion: The performance of the clinical pharmacist in intensive care units was well accepted by the medical team. The various possibilities of interventions contribute to rational use of drugs and, in addition, some of these pharmaceutical interventions have a direct impact on cost savings. Eduarda C. MacielRenan P. BorgesÁquila S. PortelaSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 10, Iss 4 (2020)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Eduarda C. Maciel Renan P. Borges Áquila S. Portela Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
description	Objective: Evaluate the performance of the clinical pharmacist in Adult Intensive Care Units of a special-sized hospital, wherein pharmacotherapeutic follow-up is the main activity developed by the pharmacist residing in intensive care. Methods: This is an observational, cross-sectional study with a quantitative approach, carried out in Adult Intensive Care Units, from March to June 2018. Data were collected from the Clinical Pharmacy Service, by means of already established indicators. Results: During the study period, 958 patients were admitted and 664 were included in the study. Regarding the place of hospitalization, 57% of the patients included in the study were hospitalized in the Post-operative Intensive Care Unit and 43% in the Clinical Intensive Care Unit. The suggested interventions were well accepted (99.6%), and in the clinical intensive care unit, the number of interventions performed and the cost saving were higher in all months of the study. The main interventions were drugs inclusion / withdrawal, dose reduction, infusion time and dilution. Of the interventions accepted, 25% generated cost savings, saving R $ 163,656.40 in total, and the types of interventions related to the most frequent cost saving were withdrawal of the drug (58.5%), dose reduction (32.6%) and change of pharmaceutical formula (3.0%). Conclusion: The performance of the clinical pharmacist in intensive care units was well accepted by the medical team. The various possibilities of interventions contribute to rational use of drugs and, in addition, some of these pharmaceutical interventions have a direct impact on cost savings.
format	article
author	Eduarda C. Maciel Renan P. Borges Áquila S. Portela
author_facet	Eduarda C. Maciel Renan P. Borges Áquila S. Portela
author_sort	Eduarda C. Maciel
title	Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
title_short	Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
title_full	Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
title_fullStr	Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
title_full_unstemmed	Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
title_sort	pharmaceutical actuation in intensive care units: contributions to rational use of drugs
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2020
url	https://doaj.org/article/d0dc9877dd8d4e70984ff95ed9dc592a
work_keys_str_mv	AT eduardacmaciel pharmaceuticalactuationinintensivecareunitscontributionstorationaluseofdrugs AT renanpborges pharmaceuticalactuationinintensivecareunitscontributionstorationaluseofdrugs AT aquilasportela pharmaceuticalactuationinintensivecareunitscontributionstorationaluseofdrugs
_version_	1718408467577831424

Pharmaceutical actuation in intensive care units: contributions to rational use of drugs

Ejemplares similares